Matches in Wikidata for { <http://www.wikidata.org/entity/Q91766821> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- Q91766821 description "article scientifique publié en 2019" @default.
- Q91766821 description "artículu científicu espublizáu en mayu de 2019" @default.
- Q91766821 description "scientific article published on 06 May 2019" @default.
- Q91766821 description "wetenschappelijk artikel" @default.
- Q91766821 description "наукова стаття, опублікована 6 травня 2019" @default.
- Q91766821 name "The FOsmetpantotenate Replacement Therapy (FORT) randomized, double-blind, Placebo-controlled pivotal trial: Study design and development methodology of a novel primary efficacy outcome in patients with pantothenate kinase-associated neurodegenerati" @default.
- Q91766821 name "The FOsmetpantotenate Replacement Therapy (FORT) randomized, double-blind, Placebo-controlled pivotal trial: Study design and development methodology of a novel primary efficacy outcome in patients with pantothenate kinase-associated neurodegenerati" @default.
- Q91766821 type Item @default.
- Q91766821 label "The FOsmetpantotenate Replacement Therapy (FORT) randomized, double-blind, Placebo-controlled pivotal trial: Study design and development methodology of a novel primary efficacy outcome in patients with pantothenate kinase-associated neurodegenerati" @default.
- Q91766821 label "The FOsmetpantotenate Replacement Therapy (FORT) randomized, double-blind, Placebo-controlled pivotal trial: Study design and development methodology of a novel primary efficacy outcome in patients with pantothenate kinase-associated neurodegenerati" @default.
- Q91766821 prefLabel "The FOsmetpantotenate Replacement Therapy (FORT) randomized, double-blind, Placebo-controlled pivotal trial: Study design and development methodology of a novel primary efficacy outcome in patients with pantothenate kinase-associated neurodegenerati" @default.
- Q91766821 prefLabel "The FOsmetpantotenate Replacement Therapy (FORT) randomized, double-blind, Placebo-controlled pivotal trial: Study design and development methodology of a novel primary efficacy outcome in patients with pantothenate kinase-associated neurodegenerati" @default.
- Q91766821 P1433 Q91766821-3547499F-E5A0-49AB-86BE-865EBB2E4ACE @default.
- Q91766821 P1476 Q91766821-DC628D89-7892-451C-992D-4EBD4F2AEC5B @default.
- Q91766821 P2093 Q91766821-2005FAC8-70C9-458F-ACA9-EF1F854A58C6 @default.
- Q91766821 P2093 Q91766821-2946EEE8-8338-47AB-A30B-B6C71DD5A276 @default.
- Q91766821 P2093 Q91766821-40B665FB-E4EE-4D50-B60E-FE61AE2333B2 @default.
- Q91766821 P2093 Q91766821-54C021B3-78FB-4A14-8C8F-C4A9AB94A5EB @default.
- Q91766821 P2093 Q91766821-82FB0251-67EC-4960-92D9-05529E590BCB @default.
- Q91766821 P2093 Q91766821-B9382368-5C18-4D36-9306-0FF460BC8506 @default.
- Q91766821 P2093 Q91766821-FBDD4255-A037-42DA-9841-CC36F9966416 @default.
- Q91766821 P2860 Q91766821-114A8491-9742-4FA4-97A5-326A381F249C @default.
- Q91766821 P2860 Q91766821-1A967126-AE05-4C80-853B-F67E52B09A9B @default.
- Q91766821 P2860 Q91766821-63F9B1DA-8707-4F29-9EEF-1E6F9996463A @default.
- Q91766821 P2860 Q91766821-75F94CA8-8999-4C67-9FEB-B5E08D8C2A09 @default.
- Q91766821 P2860 Q91766821-7818F789-DCBD-48A7-B493-BA93B2794630 @default.
- Q91766821 P2860 Q91766821-9E40CF94-5C40-4ABA-8AB2-DA8436FE4E27 @default.
- Q91766821 P2860 Q91766821-9EA5B88E-10E4-45C7-A578-B2E7CD2C42FB @default.
- Q91766821 P2860 Q91766821-AC684F17-61D2-4BFC-B375-525F4EA81CCC @default.
- Q91766821 P2860 Q91766821-AD7F235D-8E2D-4333-A6B9-DA595C3131BC @default.
- Q91766821 P2860 Q91766821-D4DE9C03-87BF-4CC2-B895-69BB3489035E @default.
- Q91766821 P2860 Q91766821-D6814005-CE11-4FBA-96A9-78ECAD216A8E @default.
- Q91766821 P2860 Q91766821-E5538783-13BC-4C26-9E6F-099ABB03188A @default.
- Q91766821 P2860 Q91766821-E97D8327-8584-4515-8D18-1794C524FEE8 @default.
- Q91766821 P2860 Q91766821-F395818A-A59A-42D8-94A4-EEFFF0859670 @default.
- Q91766821 P2860 Q91766821-FD5DA373-4EC8-46D9-A8BF-01B8061C1FD7 @default.
- Q91766821 P304 Q91766821-3CD804F6-9FFE-4CB0-8547-DF6EE9DA0C0D @default.
- Q91766821 P31 Q91766821-8EDA1E87-5ACF-46C1-B025-F4845950EFCD @default.
- Q91766821 P356 Q91766821-24D734D8-A51F-4816-826C-4E49DD4B4D94 @default.
- Q91766821 P433 Q91766821-244B6CB1-E056-4640-997E-FACAAA71FA28 @default.
- Q91766821 P478 Q91766821-B6309492-B8BF-4024-BE19-EA2344051470 @default.
- Q91766821 P577 Q91766821-90864DA2-F732-405F-B0BD-9D68F706E258 @default.
- Q91766821 P698 Q91766821-837214F0-B86F-41F5-B75F-21CF9477927F @default.
- Q91766821 P921 Q91766821-6CE318EC-E933-437A-841A-5B39B11B5D2D @default.
- Q91766821 P932 Q91766821-EB295A21-686A-4796-892D-7DA2ACD7A5E3 @default.
- Q91766821 P356 1740774519845673 @default.
- Q91766821 P698 31055958 @default.
- Q91766821 P1433 Q5133802 @default.
- Q91766821 P1476 "The FOsmetpantotenate Replacement Therapy (FORT) randomized, double-blind, Placebo-controlled pivotal trial: Study design and development methodology of a novel primary efficacy outcome in patients with pantothenate kinase-associated neurodegeneration" @default.
- Q91766821 P2093 "Aleksandar Videnovic" @default.
- Q91766821 P2093 "Belen Perez-Dueñas" @default.
- Q91766821 P2093 "Feriandas Greblikas" @default.
- Q91766821 P2093 "Maria L Escolar" @default.
- Q91766821 P2093 "Randall D Marshall" @default.
- Q91766821 P2093 "Sarah Tuller" @default.
- Q91766821 P2093 "Thomas Klopstock" @default.
- Q91766821 P2860 Q28205616 @default.
- Q91766821 P2860 Q28210032 @default.
- Q91766821 P2860 Q28303208 @default.
- Q91766821 P2860 Q29615569 @default.
- Q91766821 P2860 Q30355488 @default.
- Q91766821 P2860 Q34114747 @default.
- Q91766821 P2860 Q34344163 @default.
- Q91766821 P2860 Q38084855 @default.
- Q91766821 P2860 Q38785354 @default.
- Q91766821 P2860 Q40068279 @default.
- Q91766821 P2860 Q48504041 @default.
- Q91766821 P2860 Q50465734 @default.
- Q91766821 P2860 Q52664420 @default.
- Q91766821 P2860 Q56880216 @default.
- Q91766821 P2860 Q92152303 @default.
- Q91766821 P304 "410-418" @default.
- Q91766821 P31 Q13442814 @default.
- Q91766821 P356 "10.1177/1740774519845673" @default.
- Q91766821 P433 "4" @default.
- Q91766821 P478 "16" @default.
- Q91766821 P577 "2019-05-06T00:00:00Z" @default.
- Q91766821 P698 "31055958" @default.
- Q91766821 P921 Q269829 @default.
- Q91766821 P932 "6661719" @default.